TFF Pharmaceuticals, Inc. (TFFP)
NASDAQ: TFFP · Real-Time Price · USD
0.308
-0.014 (-4.38%)
Dec 3, 2024, 12:26 PM EST - Market open
TFF Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 1.16 | 0.73 | 0.5 | 0.09 | - | - | |
| Revenue Growth (YoY) | 24.55% | 48.02% | 462.39% | - | - | - | |
| Cost of Revenue | 10.7 | 11.97 | 18.42 | 21.26 | 10.68 | - | |
| Gross Profit | -9.54 | -11.24 | -17.93 | -21.17 | -10.68 | - | |
| Selling, General & Admin | 9.17 | 10.66 | 13.87 | 10.62 | 8.01 | 3.17 | |
| Research & Development | - | - | - | - | - | 8.82 | |
| Operating Expenses | 9.17 | 10.66 | 13.87 | 10.62 | 8.01 | 11.99 | |
| Operating Income | -18.7 | -21.89 | -31.8 | -31.79 | -18.69 | -11.99 | |
| Interest & Investment Income | 0.24 | 0.27 | 0.03 | 0.05 | 0.13 | 0.12 | |
| Other Non Operating Income (Expenses) | -0.06 | 0.39 | - | 0.7 | - | - | |
| Pretax Income | -18.52 | -21.24 | -31.77 | -31.04 | -18.57 | -11.87 | |
| Net Income | -18.52 | -21.24 | -31.77 | -31.04 | -18.57 | -11.87 | |
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 24.81 | |
| Net Income to Common | -18.52 | -21.24 | -31.77 | -31.04 | -18.57 | -36.68 | |
| Shares Outstanding (Basic) | 3 | 2 | 1 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 3 | 2 | 1 | 1 | 1 | 0 | |
| Shares Change (YoY) | 95.66% | 49.48% | 20.78% | 21.52% | 195.80% | 98.20% | |
| EPS (Basic) | -5.78 | -11.85 | -26.49 | -31.26 | -22.73 | -132.79 | |
| EPS (Diluted) | -5.78 | -11.85 | -26.49 | -31.26 | -22.73 | -132.79 | |
| Free Cash Flow | -12.64 | -16.13 | -28.89 | -30.43 | -17.72 | -11.22 | |
| Free Cash Flow Per Share | -3.95 | -9.00 | -24.09 | -30.64 | -21.69 | -40.61 | |
| Operating Margin | -1610.75% | -2983.45% | -6413.16% | -36055.24% | - | - | |
| Profit Margin | -1595.04% | -2894.68% | -6407.77% | -35206.85% | - | - | |
| Free Cash Flow Margin | -1088.29% | -2198.34% | -5827.59% | -34511.26% | - | - | |
| EBITDA | -18.15 | -21.39 | -31.41 | -31.68 | - | - | |
| D&A For EBITDA | 0.55 | 0.5 | 0.39 | 0.11 | - | - | |
| EBIT | -18.7 | -21.89 | -31.8 | -31.79 | -18.69 | -11.99 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.